SLS Stock Analysis: Buy, Sell, or Hold?
SLS - SELLAS Life Sciences Group, Inc. Common Stock
$13.19
1.44 (12.26%)
▲
5d:
+3.37%
30d:
+75.17%
90d:
+167.55%
BUY
MODERATE Confidence
Analysis Updated: Jul 17, 2026 12:00 AM ET
Earnings: Aug 11, 2026
23d
Smart Money Accumulation
None View Scanner →
Strength: 6.9/10
Get Alerted When SLS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SLS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: SLS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: SLS is currently trading at $13.19, which is considered slightly high relative to its 30-day fair value range of $8.25 to $13.81.
Technical Outlook: Technically, SLS is in a strong uptrend. Immediate support is located at $11.40, while resistance sits at $15.57. The stock is showing strong short-term momentum, up 12.3% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $27.50 (+108.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SLS is in a strong uptrend. Immediate support is located at $11.40, while resistance sits at $15.57. The stock is showing strong short-term momentum, up 12.3% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $27.50 (+108.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$8.25 -
$13.81
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+12.3%)
- BULLISH: Trading 108.5% below Wall St target ($27.50)
Trading Range Analysis
30-Day Trading Range
$8.25 -
$13.81
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$11.40
Resistance Level
$15.57
Current Trend
Strong Uptrend
Technical data as of
Jul 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-105.52
Wall Street Target
$27.50
(+108.5%)
Revenue Growth (YoY)
-82.5%
Share & Embed Analysis
Last updated: July 18, 2026 5:25 PM ET
Data refreshes hourly during market hours. Next update: 6:25 PM
Data refreshes hourly during market hours. Next update: 6:25 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 60 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 57 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 49 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 54 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
Advanced SLS Option Strategies
Professional options setups generated by AI based on today's SLS price and gamma walls.
